chloroquine has been researched along with Intraocular Pressure in 7 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
Intraocular Pressure: The pressure of the fluids in the eye.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirty-six eyes of 36 patients with rheumatoid arthritis (RA) were divided into two groups: group 1 included 26 patients receiving chloroquine therapy; group 2 included the other 10 patients, not receiving chloroquine therapy." | 7.78 | Chloroquine keratopathy of rheumatoid arthritis patients detected by in vivo confocal microscopy. ( He, D; He, L; Ma, X; Xu, J, 2012) |
| "Thirty-six eyes of 36 patients with rheumatoid arthritis (RA) were divided into two groups: group 1 included 26 patients receiving chloroquine therapy; group 2 included the other 10 patients, not receiving chloroquine therapy." | 3.78 | Chloroquine keratopathy of rheumatoid arthritis patients detected by in vivo confocal microscopy. ( He, D; He, L; Ma, X; Xu, J, 2012) |
| " However, the melatonin analogue, 5-methoxycarbonylamino-N-acetyltryptamine (5-MCA-NAT), reduces intraocular pressure (IOP) via MT(3) melatonin receptors." | 3.75 | 5-MCA-NAT does not act through NQO2 to reduce intraocular pressure in New-Zealand white rabbit. ( Alarma-Estrany, P; Crooke, A; Pintor, J, 2009) |
| "Mean intraocular pressure was 12 mmHg (standard deviation, 4." | 1.35 | Ocular manifestation in treated multibacillary Hansen's disease. ( Muliyil, J; Parikh, R; Parikh, S; Thomas, R; Thomas, S, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alarma-Estrany, P | 1 |
| Crooke, A | 1 |
| Pintor, J | 1 |
| Parikh, R | 1 |
| Thomas, S | 1 |
| Muliyil, J | 1 |
| Parikh, S | 1 |
| Thomas, R | 1 |
| Ma, X | 1 |
| He, L | 1 |
| He, D | 1 |
| Xu, J | 1 |
| Thurn, G | 1 |
| Chrzanowska-Srzednicka, K | 1 |
| Ciechanowska, A | 1 |
| Robertson, DM | 1 |
2 reviews available for chloroquine and Intraocular Pressure
| Article | Year |
|---|---|
[Negative influence of some agents on eye condition in primary glaucoma].
Topics: Adrenal Cortex Hormones; Atropine; Chloroquine; Cholinesterase Inhibitors; Epinephrine; Eye; Feedbac | 1972 |
The eye and adverse drug effects. Some selected considerations.
Topics: Acetazolamide; Amyl Nitrite; Anesthesia; Chloramphenicol; Chloroquine; Contraceptives, Oral; Dexamet | 1972 |
5 other studies available for chloroquine and Intraocular Pressure
| Article | Year |
|---|---|
5-MCA-NAT does not act through NQO2 to reduce intraocular pressure in New-Zealand white rabbit.
Topics: Amino Acid Sequence; Animals; Base Sequence; Chloroquine; Ciliary Body; Cornea; Humans; Immunohistoc | 2009 |
Ocular manifestation in treated multibacillary Hansen's disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blindness; Cataract; Child; Chloroquine; Corneal Disease | 2009 |
Chloroquine keratopathy of rheumatoid arthritis patients detected by in vivo confocal microscopy.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; China; Chloroquine; Cornea; Corneal Diseas | 2012 |
[Side effects of various drugs acting on the eye].
Topics: Cardiac Glycosides; Chloroquine; Contraceptives, Oral; Cyproheptadine; Drug-Related Side Effects and | 1972 |
Iatrogenic symptoms in ophthalmology.
Topics: Accommodation, Ocular; Chloroquine; Drug-Related Side Effects and Adverse Reactions; Eye Diseases; H | 1969 |